Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 3.
doi: 10.1002/mdc3.70340. Online ahead of print.

The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders

Tommaso Ercoli  1 , Christian Geroin  2   3 , Enrico Marcuzzo  3 , Angela Sandri  3 , Luigi Michele Romito  4 , Roberto Eleopra  4 , Lucia Tesolin  5 , Francesco de Bertoldi  6 , Alessandra Nicoletti  7 , Giovanni Mostile  7   8 , Alessandro Padovani  9   10   11   12   13 , Andrea Pilotto  9   10   11   12 , Nicola Modugno  14 , Enrica Olivola  14 , Benedetta Demartini  15   16 , Veronica Nisticò  17 , Roberto Erro  18 , Sofia Cuoco  18 , Alessandro Tessitore  19 , Rosa De Micco  19 , Roberto Ceravolo  20 , Eleonora Del Prete  20 , Carlo Dallocchio  21 , Carla Arbasino  21 , Francesco Bono  22 , Cataldo Mummolo  22 , Marcello Esposito  23 , Assunta Trinchillo  24 , Giovanni Fabbrini  14   25 , Gina Ferrazzano  25 , Martina Petracca  26 , Carla Piano  26   27 , Laura Bonanni  28 , Claudia Carrarini  29 , Alberto Albanese  30 , Carlo Alberto Artusi  31   32 , Giovanni Defazio  33 , Paola Caruso  34 , Giovanna Calandra-Buonaura  35   36 , Francesca Morgante  37 , Antonio Pisani  38   39 , Paolo Solla  1 , Michele Tinazzi  3 ; Italian Registry of Functional Motor Disorders (IRFMD) study group
Affiliations

The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders

Tommaso Ercoli et al. Mov Disord Clin Pract. .

Abstract

Background: Functional motor disorder (FMD) is a diagnosis of inclusion based on the presence of positive signs on clinical examination, and only a few tests are validated as biomarkers for FMD identification.

Objectives: The aim of this study was to assess the relative frequency of different types of conventional instrumental investigations (such as magnetic resonance imaging/computed tomography [MRI/CT] scan, dopamine transporter single-photon emission computed tomography (DaT-SPECT), electroencephalography (EEG), neurophysiological tests, and other tests) in FMD patients before diagnosis and to identify the clinical and demographic features associated with their use.

Methods: Data were obtained from the Italian Registry of Functional Motor Disorders, a multicenter initiative involving patients with a diagnosis of clinically definite FMD. Patients were consecutively enrolled at 25 Italian centers during 2 phases. Data collection initially took place between September 2018 and August 2019, and during phase 2, between January 2020 and December 2022.

Results: Among the 853 patients included during the 2 phases of the registry, we identified 794 patients (93.1%) who underwent 1 or more categories of conventional investigations. Overall, conventional investigations were more likely to be performed in older FMD patients (Odds ratio [OR]: 1.02; P = 0.013). Interestingly, we found that more than one category of investigation was more likely to be performed in FMD patients presenting with weakness (OR: 1.85; P = 0.002) and with additional functional symptoms (OR: 1.54; P = 0.026).

Conclusions: Our findings provide novel insights into the complex diagnostic process of FMD patients. This study highlights the need to identify reliable biomarkers that may help physicians diagnose FMD earlier and carefully select the most appropriate conventional investigations.

Keywords: conventional investigations; diagnosis; functional motor disorders; functional neurological disorders.

PubMed Disclaimer

References

    1. Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neur 2022;21(6):537–550. https://doi.org/10.1016/S1474-4422(21)00422-1.
    1. Serranová T, Di Vico I, Tinazzi M. Functional movement disorder. Neurol Clin 2023;41(4):583–603. https://doi.org/10.1016/j.ncl.2023.02.002.
    1. Lidstone SC, Costa‐Parke M, Robinson EJ, Ercoli T, Stone J. Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta‐analysis of 4905 cases. J Neurol Neurosurg Psychiatry 2022;93(6):609–616. https://doi.org/10.1136/jnnp-2021-328462.
    1. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2009;22(1473‐6551):430–436.
    1. Stone J, Burton C, Carson A. Recognising and explaining functional neurological disorder. BMJ 2020;371:m3745. https://doi.org/10.1136/bmj.m3745.

LinkOut - more resources